Healthcare

• Helus Pharma will participate in the Morgan Stanley Healthcare Conference, where Michael Halstead will give a fireside chat on September 16. • The chat will be webcast live at 8:30 a.m. EDT and a replay will be available on Helus Pharma's investor relations website. • The company's products, including HLP003 and HLP004, have not been evaluated by regulatory authorities such as the US Food and Drug Administration, and their efficacy has not been confirmed by approved research.

• Modern Healthcare is tracking the latest news on mergers, acquisitions, and joint partnerships in the healthcare industry. • The publication provides live updates on deals as they happen, giving readers insight into the changing healthcare landscape. • This coverage helps healthcare professionals and investors stay informed about potential opportunities and challenges in the market.

• European healthcare technology is shifting from a speculative, growth-focused environment toward an industrial phase prioritizing capital efficiency and clinical efficacy. • The sector is currently facing increasingly intense and complex cybersecurity threats, leading organizations to increase spending on security measures. • This transition toward regulatory defensibility and efficiency is expected to accelerate growth in the lower to mid-market investment banking space from 2026 to 2030.

• A mother is protesting UnitedHealthcare's decision to deny coverage for her 25-year-old son's rehabilitation following a motorcycle accident. • The mother described feeling helpless, frustrated, and angry that the insurance company is refusing to provide the care she believes gives her son the best chance at recovery. • This denial leaves the family facing the financial burden of paying for essential medical recovery services out of pocket.

• Over 100 tech giants, including OpenAI, Google, Microsoft, Amazon Web Services, and Anthropic, have issued a joint public appeal warning of imminent AI-enabled hacking. • The letter specifically targets critical infrastructure sectors such as energy, healthcare, financial services, and water systems, urging them to bolster their digital defenses. • This warning matters because AI-powered cyber intrusions are becoming more sophisticated, potentially threatening the stability of essential public services.

• The European Central Bank (ECB) has issued warnings regarding a potential market correction and the collapse of an AI-driven technology bubble. • Analysts highlight systemic vulnerabilities in the Eurozone's financial architecture caused by extreme market concentration in the U.S. "Magnificent Seven" equities. • This exposure matters because a sharp decline in the valuations of giants like Nvidia, Microsoft, and Alphabet could trigger broader financial instability across Europe.

• Axis Max Life CIO Sachin Bajaj reports that Indian equities are entering a favorable phase driven by recovering earnings, moderate valuations, and strong domestic flows. • Bajaj specifically recommends investing in financials, healthcare, capital goods, digital platforms, and manufacturing beneficiaries, while advising caution regarding overpriced stocks. • Fundamental outlooks have improved as Q1 FY27 earnings growth is exceeding expectations and high-frequency economic indicators signal sustained positive momentum.

Earlier this week prosecutors and Luigi Mangione’s lawyers filed a joint letter requesting the hearing at 11am on Friday in Manhattan federal courtLuigi Mangione, is reportedly expected to plead guilty at a scheduled hearing on Friday in Manhattan federal court, where he faces charges of stalking resulting in the death of Brian Thompson, the chief of executive of UnitedHealthcare, in 2024.The potential plea deal in the federal case, which NBC News and the New York Times (paywall) reported on Thursday, comes less a month out from a scheduled trial on 8 September on a New York state murder charge in connection with Thompson’s fatal shooting. The federal trial for the stalking charges in connection with the killing of Thompson is due to take place in January, and carries a potential life sentence. Continue reading...

Prosecutors allege 28-year-old gunned down Brian Thompson outside Manhattan hotel in 2024Luigi Mangione, who is accused of the killing of the UnitedHealthcare CEO Brian Thompson, is due to appear on Tuesday morning at Manhattan state court.Mangione’s appearance comes less than a month before the start of his highly anticipated 8 September trial. Prosecutors allege that Mangione gunned down Thompson outside a Midtown Manhattan hotel on 4 December 2024. Continue reading...

• European stocks experienced a mixed trading session, closing lower overall as declines in Italy outweighed gains seen in the healthcare sector. • Market volatility was driven by ongoing geopolitical risks, though specific sectors provided a partial buffer against broader losses. • A top investor in Volkswagen has urged the automaker to take decisive action, adding corporate pressure to the regional market sentiment.

• Commissioner Chen Chun-An of Taipei's Department of Economic Development led a delegation of 15 technology companies to Osaka, Kobe, and Kyoto, Japan, from June 30 to July 3, 2026. • The initiative, organized by StartUP@Taipei, focused on strengthening AI healthcare ecosystems and fostering innovation linkages between Taiwan and Japan's Kansai region. • This collaboration matters as it aims to expand market reach for Taiwanese startups and integrate advanced AI healthcare solutions into the Japanese medical landscape.

• The FDA has introduced a new fast-track program for the approval of biologics, which are complex drugs used to treat conditions such as cancer and sickle cell disease. • Traditionally, the agency requires a rigorous process involving an investigational new drug application followed by three distinct phases of human clinical trials. • Experts warn that these political shortcuts could undermine the FDA's international reputation and its standing as a global authority on drug safety.

• House Republicans have launched "reconciliation 3.0," introducing a $95 billion draft budget resolution. • The proposed budget is not health-focused, instead prioritizing defense spending, voting integrity efforts, and aid for farmers. • Other key legal and legislative activities this week include Senate HELP Committee nomination hearings and discussions on patent eligibility.

• The CDC reported a decline in healthcare-associated infections (HAIs) for the year 2023, signaling a positive trend in patient safety. • This decrease indicates that hospitals are successfully implementing better infection control measures and safety protocols to protect patients. • The findings matter as reducing HAIs lowers patient morbidity, decreases hospital stay durations, and reduces overall healthcare costs.

• The WHO Europe chief has warned that AI tools are being rapidly deployed in healthcare across 53 member countries without sufficient oversight. • Data reveals a stark imbalance: while two-thirds of these nations use AI for diagnostics and half use AI chatbots, only 8% (one in twelve) have a health-specific AI strategy. • This lack of governance risks causing biased diagnoses and eroding public trust in healthcare systems.

• India is integrating artificial intelligence into its healthcare system to improve diagnostic access, specifically through the use of AI-driven medical scans and eye disease detection. • A tool developed by the Bengaluru-based company Remidio allows healthcare workers with limited specialist training to perform initial eye screenings, expanding reach to underserved areas. • Medical professionals emphasize that AI is intended to function as a supportive tool for clinicians rather than a replacement for human doctors.

• The FDA has introduced a new fast-track program for the approval of biologics, including experimental gene therapies for conditions like sickle cell disease and cancer. • Traditionally, the agency requires a rigorous three-phase trial process involving healthy volunteers, dose-finding studies, and large-scale clinical trials to ensure safety. • Critics argue that these political shortcuts may undermine the FDA's international reputation and its standing as a global authority on drug safety.

• Congress has returned from recess to prioritize bipartisan healthcare legislation, specifically targeting prior authorization reform and the expansion of remote patient monitoring. • Key legislative goals include extending Affordable Care Act (ACA) premium tax credits to maintain insurance affordability for millions of Americans. • Regulatory updates from CMS and the FDA introduce critical changes to 340B drug pricing policies and hospital outpatient payment systems.

Partnered Health says personal information and medical details and notes were breached in the attack on 21 clinics Get our breaking news email, free app or daily news podcastThousands of medical records and patient information stored with one of Australia’s biggest healthcare providers have been breached in a cyber-attack.Partnered Health, owned by private equity firm Quadrant, said 21 clinics across several cities including Sydney, Melbourne and Canberra have been affected by the breach which occurred on 23 June. Continue reading...

• Sanofi's stock price has remained steady as of July 13, 2026, reflecting the company's stable market position within the global pharmaceutical industry. • The company's long-term growth is supported by a diversified portfolio that includes prescription medicines, vaccines, and consumer health products. • This stability is driven by consistent global demand for healthcare services, providing a reliable foundation for long-term investors.

• Japan has partnered with the company Noetra to deploy 10 million robots across 18 different job sectors by 2040. • The initiative focuses on integrating "physical AI" into critical industries, specifically targeting healthcare and food manufacturing to improve efficiency. • This large-scale deployment is designed to address Japan's severe labor shortages and the need for increased productivity in the workforce.

New report details slew of ventures between private equity and nonprofits and calls for greater government oversight A watchdog group is calling for greater government oversight of joint ventures between private equity firms and non-profit healthcare providers, arguing that the arrangements could present “risks” to “patients, payers and employees”.In a new report, Private Equity Stakeholder Project (PESP), a vocal critic of the industry, detailed more than 500 joint ventures between private equity and nonprofit healthcare providers – ranging from rural hospitals to major religiously affiliated health systems to hospice care providers. The group argued those risks could include extraction of profit and a decline in quality of care. Continue reading...

• National TV drug advertising spending rose 16% year-over-year in 2025, with the most significant growth occurring in the cancer, mental health, and weight loss categories. • Despite increased FDA enforcement regarding pharmaceutical advertising, industry experts believe sweeping rule changes are unlikely to occur in the near future. • Pharma marketers are maintaining their linear TV investments for high-impact disease areas and major events while simultaneously expanding into targeted CTV and digital campaigns.

• Between June 27 and July 4, 2026, the FDA issued two major approvals: expanding Casgevy gene therapy for sickle cell disease patients aged 2 and older, and approving Tregzi, the first Treg cell immunotherapy for chronic graft-versus-host disease. • The roundup also tracks critical healthcare developments across the US, UK, Canada, Australia, and the EU, including NHS funding updates, EMA regulatory decisions, and various biotech deals. • These updates are significant for clinicians, biotech investors, and policy watchers as they signal advancements in gene therapy and hospital consolidation trends.

• The U.S. healthcare system is facing a potential crisis as a Supreme Court ruling could pave the way for mass deportations. • Experts warn that these deportations would exacerbate existing staffing shortfalls in hospitals and emergency rooms, with the long-term healthcare sector expected to suffer the most significant disruptions. • This situation matters because the removal of migrant workers would further destabilize a medical infrastructure already struggling to meet patient needs.

• Federal authorities executed the largest healthcare fraud takedown of 2026, charging 455 defendants, including 90 doctors. • The operation targeted $6.5 billion in false claims and uncovered cases involving patient deaths. • This massive enforcement action highlights critical vulnerabilities in healthcare billing and the severe legal consequences of systemic fraud.

• HCA Healthcare has announced a new study published in the New England Journal of Medicine (NEJM) highlighting advancements in CRISPR-based therapies for children. • The research builds upon pioneering work at TriStar Centennial Medical Center and the Sarah Cannon Transplant and Cellular Therapy Network, which performs over 1,600 cellular therapies and transplants annually. • Dr. Frangoul, a key investigator, previously contributed to the first U.S. clinical trial for gene-editing in sickle cell disease, leading to the first FDA-approved CRISPR therapy.

• National data reveals that Assam has accounted for nearly 62% of all Japanese encephalitis (JE) deaths in India since 2018, with outbreaks typically peaking between July and August. • Expert Athira Elssa Johnson emphasizes the urgent need for India to improve controls on food-borne infections, which are being exacerbated by climate change, chemical contaminants, and antimicrobial resistance (AMR). • The report further highlights the growing threat of drug-resistant malaria, which is complicating current medical treatment and disease elimination efforts.